Pharma CEOs Counter Trump By Promising Safety Over Shortcuts In Coronavirus Vaccine Development

The chief executives of nine pharmaceuticals signed a pledge Tuesday saying they won’t submit their coronavirus vaccines for regulatory approval unless large clinical trials prove them to be safe and effective, countering President Trump’s previous insistence that a vaccine will be ready by November’s election. The companies that signed the pledge are: AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi. The CEOs “want to make clear our on-going commitment to developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles,” according to the pledge.